111 related articles for article (PubMed ID: 63624)
1. [Products of fibrinogen splitting and their biological significance (literature survey)].
Timoshenko LI
Lab Delo; 1976; (9):515-20. PubMed ID: 63624
[No Abstract] [Full Text] [Related]
2. The clinical significance of fibrinogen degradation products.
Bick RL
Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
[No Abstract] [Full Text] [Related]
3. Hematologic changes and thromboembolic complications in neoplastic disease and their relationship to metastasis.
Ambrus JL; Ambrus CM; Pickern J; Soldes S; Bross I
J Med; 1975; 6(5-6):433-58. PubMed ID: 130433
[No Abstract] [Full Text] [Related]
4. [Hemostatic mechanisms and malignant tumors].
Kase F; Pospísil J; Hlousková D
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
Lychev VG; Momot AP; Cherkashin GV
Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
[TBL] [Abstract][Full Text] [Related]
6. [Intravascular blood coagulation and its role in malignant neoplasms].
Pavlovskiĭ DP
Vopr Onkol; 1981; 27(7):96-103. PubMed ID: 7023043
[No Abstract] [Full Text] [Related]
7. Renal disease and fibrinogen degradation products.
Hedner U; Nilsson IM
Adv Nephrol Necker Hosp; 1974; 3():241-71. PubMed ID: 4219704
[No Abstract] [Full Text] [Related]
8. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
Heene DL; Genth K
Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
[No Abstract] [Full Text] [Related]
9. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
10. Problems of diagnosis of disseminated intravascular coagulation (DIC).
Bowie EJ; Owen CA
Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
[TBL] [Abstract][Full Text] [Related]
11. [Intravascular coagulation of the blood in liver cirrhosis (a review of the literature)].
Shelest LIu; Sushko EA; Shkapko VD; Shekhter IE; Ena IaM
Vrach Delo; 1990 Aug; (8):44-7. PubMed ID: 2256285
[No Abstract] [Full Text] [Related]
12. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
Astrup T; Jespersen J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of disseminated intravascular coagulation.
Larrieu MJ
Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):321-4. PubMed ID: 515795
[No Abstract] [Full Text] [Related]
14. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
Horiuchi N; Aoki Y; Terada H
Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
[No Abstract] [Full Text] [Related]
16. [Comparison of 2 tests for determining lytic products of fibrin].
Chalini-Carreon F; Ortiz-Méndez VM; Olvera-Hidalgo C; Magaña-Pérez JA
Bol Med Hosp Infant Mex; 1983 Nov; 40(11):613-7. PubMed ID: 6651948
[No Abstract] [Full Text] [Related]
17. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
[TBL] [Abstract][Full Text] [Related]
18. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
Mombelli G; Fiori G; Monotti R; Haeberli A; Straub PW
J Lab Clin Med; 1993 Jan; 121(1):83-90. PubMed ID: 8426084
[TBL] [Abstract][Full Text] [Related]
19. Distinction between fibrinogen and fibrin degradation products produced during disseminated intravascular coagulation in childhood.
Yoshioka K; Mizuno S; Miyata H; Maki S
Eur J Pediatr; 1982 Feb; 138(1):46-8. PubMed ID: 7075627
[No Abstract] [Full Text] [Related]
20. Progress in the measurement of circulating fibrinogen derivatives.
Wilner GD
Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
